MELINTA THERAPT Revenue, Profits - MLNT Annual Income Statement

Add to My Stocks
$4.5 $0.05 (1.1%) MLNT stock closing price Sep 21, 2018 (Closing)

Looking at financial statements, along with the MELINTA THERAPT stock price, it's management, its economic moat, and industry competitors forms an important part of fundamental analysis. The income statement is a summary of the revenue or sales, expenses and profitability - shown as Net Income, or lack of it. Like any other income statement, the MLNT income statement also itemizes revenue/sales, operating expenses, and profits/bottomline for a quarter or year and reflects a YOY revenue growth of 88.01% when compared to the same period in the past. The MELINTA THERAPT profit and loss statement for 2017 shows a net profit of $-58.91M. Profits for last year was $-117.96M. Apart from this an investor should also check MELINTA THERAPT assets and MELINTA THERAPT free cash flow.

View revenue and profit details for latest and last 10 financial years.
show more
Quarterly
Annual
View Previous Years
View Next Years
Fiscal year is Jan - Dec201720162015201420132012201120102009
MELINTA THERAPT Revenues or Net Sales
33.86M18.01M27.3M15.21M7.81M----
Cost Of Goods Sold (COGS)---------
MELINTA THERAPT Gross Profit
33.86M18.01M27.3M15.21M7.81M----
Research & Development Expense49.47M81.68M93.35M62.53M41.29M16.86M16.87M15.47M13.67M
Selling General & Admin Expense63.32M53.53M22.87M12.07M9.43M6.06M3.7M3.19M3.02M
Income Before Depreciation Depletion Amortization-78.93M-117.2M-88.91M-59.39M-42.92M-22.93M-20.57M-18.67M-16.7M
Depreciation Depletion Amortization---------
Non Operating Income23.62M--------
Interest Expense3.6M1.22M2.2M2.38M2.13M1.39M-1.49M1.92M
MELINTA THERAPT Pretax Income
-58.91M-117.96M-91.11M-61.64M-45.03M-24.22M-21.22M-19.67M-18.61M
Provision for Income Taxes---------
MinorityInterest---------
Investment Gains Losses---------
Other Income---------
Income Before Extraordinaries & Disc Operations-58.91M-117.96M-91.11M-61.64M-45.03M-24.22M-21.22M-19.67M-18.61M
Extraordinary Items & Discontinued Operations---------
MELINTA THERAPT Profit/ Loss (Net Income)
-58.91M-117.96M-91.11M-61.64M-45.03M-24.22M-21.22M-19.67M-18.61M
Average Shares used to compute Diluted EPS3.58M10.06M8.71M6.83M5.89M3.98M---
Average Shares used to compute Basic EPS3.58M10.06M8.71M6.83M5.89M3.98M---
Income Before Nonrecurring Items-58.92M-117.96M-91.11M-61.65M-45.04M-24.54M-21.22M--
Income from Nonrecurring Items---------
MELINTA THERAPT Earnings Per Share Basic Net
-21.86-11.70-10.45-9.05-7.65-6.15-237.65--
MELINTA THERAPT Earnings Per Share Diluted Net
-21.86-11.70-10.45-9.05-7.65-6.15-237.65--
EPS Diluted Before Nonrecurring Items-21.86-11.70-10.45-9.05-7.65-6.15-237.65--
Preferred Dividends Acc Pd---------
Dividends Common---------
Dividend Per Share Common0.000.000.000.000.000.000.000.000.00
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Years
View Next Years

Before investing one should read a report on MELINTA THERAPT stock analysis. It helps to look at the following income statement items:

  • Top line: The word topline comes from the fact that the first line of an income statement refers to sales numbers. If you check you will find that MLNT stock has a topline or revenue of $33.86M for 2017 as per this MELINTA THERAPT revenue chart. Investors look for stocks with a growing top line.
  • Bottom line: This refers to the last line in a profit and loss statement and denotes the net profit or loss for a particular period. The figure currently stands at $-58.91M for MELINTA THERAPT for 2017. This figure is arrived at after deducting all operating expenses, interest, and taxes from revenue.

The income statement is also called the profit and loss statement. Apart from the MLNT income statement, one can check the MELINTA THERAPT historical stock prices to check how the price has moved with time.

MELINTA THERAPT Income Statement - Key Financial Ratios

PS Ratio (price sales ratio)
5.53
Dividend Yield
0%